Volume 15, Number 4—April 2009
THEME ISSUE
The Amazon Region
Dispatches
Concurrent Dengue and Malaria in Cayenne Hospital, French Guiana
Bernard Carme
, Severine Matheus, Gerd Donutil, Olivia Raulin, Antoine Adenis, and Jacques Morvan
, Severine Matheus, Gerd Donutil, Olivia Raulin, Antoine Adenis, and Jacques Morvan
Table
Clinical course and diagnosis in 17 case-patients with confirmed or suspected concurrent dengue and malaria, Cayenne Hospital, Cayenne, French Guiana, July 2004–June 2005*
| Patient no./birth year | Malaria diagnosis |
Hospitalized† | Initial diagnosis and clinical signs | Dengue diagnosis |
Conclusion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Species | Parasitemia |
IgM | RT-PCR | Iso | ||||||
| % | Class | |||||||||
| 1/1983 | Pv | <0.1 | C3 | No | Malaria | – | + DEN-1 | ND | Confirmed acute concurrent disease | |
| 2/1984 | Pv | 0.15 | C4 | No | Malaria, Tp 51,000 | – | + DEN-3 | ND | Confirmed acute concurrent disease | |
| 3/1973 | Pv | 0.8 | C4 | No | Malaria | – | + DEN-3 | ND | Confirmed acute concurrent disease | |
| 4/1975 | Pf | 0.1 | C3 | No | Malaria | – | + DEN-3 | ND | Confirmed acute concurrent disease | |
| 5/1983 | Pv | 0.1 | C3 | No | Malaria | – | + DEN-3 | ND | Confirmed acute concurrent disease | |
| 6/1980 | Pv | 0.2 | C4 | No | Malaria, Tp 52,000, Hb 9.4 | SeroC | – | ND | Confirmed acute concurrent disease | |
| 7/1981 | Pf | <0.1 | C1 | No | Malaria‡ | – | ND | DEN-3 | Confirmed concurrent infection | |
| 8/1953 | Pv | <0.1 | C3 | Yes§ | Malaria, Tp 71,000 | + | – | – | Suspected concurrent infection | |
| 9/1952 | Pv | 0.8 | C4 | No | Malaria, Tp 30,000, BP 80/50 | + | – | – | Suspected concurrent infection | |
| 10/1948 | Pv | 0.3 | C4 | No | Malaria, Tp 70,000 | + | – | – | Suspected concurrent infection | |
| 11/1982 | Pv | 0.25 | C4 | No | Malaria | + | – | – | Suspected concurrent infection | |
| 12/1979 | Pf | 0.4 | C4 | Yes¶ | Malaria | + | – | – | Suspected concurrent infection | |
| 13/1956 | Pv | 0.5 | C4 | Yes# | Malaria, Tp 63,000, Hb 5.9, Sat 83% | + | – | – | Suspected concurrent infection | |
| 14/1976 | Pv | 0.7 | C4 | No | Malaria | + | – | – | Suspected concurrent infection | |
| 15/1988 | Pv | 0.5 | C4 | No | Malaria, Tp 29,000, BP 90/50 | + | – | – | Suspected concurrent infection | |
| 16/1974 | Pv | 0.1 | C3 | No | Malaria, HR 146 bpm | + | – | – | Suspected concurrent infection | |
| 17/1961 | Pv | <0.1 | C2 | No | Malaria‡ | + | – | – | Suspected concurrent infection | |
*IgM, immunoglobulin M; RT-PCR, reverse transcription–PCR; Iso, isolate; Pv, Plasmodium vivax; – , negative; + positive; DEN, dengue; ND, not done; Pf, P. falciparum; Tp, thrombocytopenia++ (<100,000 platelets/µL); Hb, hemoglobin (reference range <10 g/L); BP, arterial blood pressure (systolic/diastolic); Sat, blood oxygen saturation; HR, heart rate; bpm, beats per minute.
†Hospitalization >8 hours.
‡Possible asymptomatic carrier of Plasmodium spp.
§For diabetes requiring insulin.
¶For treatment with Riamet (arthemether + lumefantrine).
#For interstitial pneumonia.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.